AGL · NYSE
agilon health (AGL) Stock Price & Fundamentals
agilon health (AGL) closed at $559.54 on Oct 9, 2026, up 0.06% from the previous close of $559.21.
Share price, past year
1Y −3.18%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $559.54 |
| Sep 30, 2026 | $543.94 |
| Aug 31, 2026 | $573.68 |
| Jul 31, 2026 | $582.53 |
| Jun 30, 2026 | $582.27 |
| May 29, 2026 | $558.33 |
| Apr 30, 2026 | $572.99 |
| Mar 31, 2026 | $594.01 |
| Feb 27, 2026 | $576.23 |
| Jan 30, 2026 | $571.54 |
| Dec 31, 2025 | $585.51 |
| Nov 28, 2025 | $577.08 |
| Oct 31, 2025 | $566.63 |
Key statistics
- Market cap
- $9.39B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $5.92B
- Net income (TTM)
- −$232.22M
- Shares outstanding
- 16.8M
- Dividend yield
- —
- 52-week range
- $535.94 – $605.03
agilon health's market cap is $9.39B, based on a share price of $559.54 and 16.8M shares outstanding as of Jun 30, 2026.
Financials
agilon health reported revenue of $5.93B for fiscal 2025, down 2.11% from fiscal 2024.
agilon health reported a net loss of $391.35M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $5.93B | −2.1% | −$391.35M | −6.6% | — | −$119.01M |
| FY2024ended Dec 31, 2024 | $6.06B | +40.4% | −$260.15M | −4.3% | — | −$71.03M |
| FY2023ended Dec 31, 2023 | $4.32B | +80.7% | −$262.60M | −6.1% | — | −$172.03M |
| FY2022ended Dec 31, 2022 | $2.39B | +57.0% | −$106.55M | −4.5% | — | −$146.23M |
| FY2021ended Dec 31, 2021 | $1.52B | +24.9% | −$406.49M | −26.7% | — | −$154.72M |
| FY2020ended Dec 31, 2020 | $1.22B | +53.4% | −$60.05M | −4.9% | — | −$54.98M |
| FY2019ended Dec 31, 2019 | $794.41M | — | −$282.59M | −35.6% | — | −$106.75M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $1.49B | $17.96M | $1.04 |
| Q1 FY2026ended Mar 31, 2026 | $1.42B | $48.92M | $2.94 |
| Q4 FY2025ended Dec 31, 2025 | $1.57B | −$188.88M | — |
| Q3 FY2025ended Sep 30, 2025 | $1.44B | −$110.21M | — |
| Q2 FY2025ended Jun 30, 2025 | $1.39B | −$104.37M | −$6.31 |
| Q1 FY2025ended Mar 31, 2025 | $1.53B | $12.11M | $0.73 |
| Q4 FY2024ended Dec 31, 2024 | $1.52B | −$105.79M | — |
| Q3 FY2024ended Sep 30, 2024 | $1.45B | −$117.62M | — |
Company profile
- Name
- agilon health, inc.
- Ticker
- AGL
- Exchange
- NYSE
- Industry (SEC SIC)
- Services-Misc Health & Allied Services, NEC
- Headquarters
- 440 Polaris Parkway, Suite 550, Westerville, OH 43082
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001831097
Recent SEC filings
- Aug 5, 2026
- Aug 5, 2026
- Jul 22, 2026
- Jun 3, 2026
- May 6, 2026
- May 6, 2026
- Apr 27, 2026
- Mar 30, 2026
Frequently asked questions
What is agilon health's stock price?
agilon health (AGL) closed at $559.54 on Oct 9, 2026, up 0.06% from the previous close of $559.21.
What is agilon health's market cap?
agilon health's market cap is $9.39B, based on a share price of $559.54 and 16.8M shares outstanding as of Jun 30, 2026.
How much revenue does agilon health make?
agilon health reported revenue of $5.93B for fiscal 2025, down 2.11% from fiscal 2024.
Does agilon health pay a dividend?
agilon health's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from agilon health, inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures